DS HEALTHCARE GROUP CONFERENCE CALL REPLAY INFORMATION

​Due to technical difficulties from our conference call provider, the conference call passcode was not accepted properly on our update call this morning.  The system prompted callers to dial *0 to be connected to the Operator that would then connect you to the call. 

For those of you who were unable to connect, a recording of today’s conference call will be made available using one of the following two methods, where the replay will be available for 10 days.

1) Listen by calling the replay phone number 1-888-286-8010 in the United States and Canada, or 1-617-801-6888 internationally, then referencing the Conference ID 16191135#, available immediately.  

2) Listen by visiting www.dshealthgroup.com. This recording will be available starting at 12:00 pm Eastern Daylight Time on Thursday, March 31, 2016.

Note that there was no Q&A session after the call. We have provided the following number for anyone to call to have his or her individual questions answered personally by the management team: (888) 404-7770 Ext. 3

About DS Healthcare Group

DS Healthcare Group Inc. is engaged in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Health Group's flagship brand, visit www.dslaboratories.com

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at www.sec.gov

Contact

Investor Relations
DS Healthcare Group, Inc.
(888) 404-7770 Ext. 3
Investors@DSHealthGroup.com

About DS Healthcare Group

DS Healthcare Group Inc. is engaged in the development of biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons.


More Press Releases